18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Water models for biomolecular simulations : Water models for biomolecular simulations

      1 , 2 , 3 , 4
      Wiley Interdisciplinary Reviews: Computational Molecular Science
      Wiley

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references377

          • Record: found
          • Abstract: not found
          • Article: not found

          Theoretical studies of enzymic reactions: Dielectric, electrostatic and steric stabilization of the carbonium ion in the reaction of lysozyme

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            QM/MM methods for biomolecular systems.

            Combined quantum-mechanics/molecular-mechanics (QM/MM) approaches have become the method of choice for modeling reactions in biomolecular systems. Quantum-mechanical (QM) methods are required for describing chemical reactions and other electronic processes, such as charge transfer or electronic excitation. However, QM methods are restricted to systems of up to a few hundred atoms. However, the size and conformational complexity of biopolymers calls for methods capable of treating up to several 100,000 atoms and allowing for simulations over time scales of tens of nanoseconds. This is achieved by highly efficient, force-field-based molecular mechanics (MM) methods. Thus to model large biomolecules the logical approach is to combine the two techniques and to use a QM method for the chemically active region (e.g., substrates and co-factors in an enzymatic reaction) and an MM treatment for the surroundings (e.g., protein and solvent). The resulting schemes are commonly referred to as combined or hybrid QM/MM methods. They enable the modeling of reactive biomolecular systems at a reasonable computational effort while providing the necessary accuracy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              How fast-folding proteins fold.

              An outstanding challenge in the field of molecular biology has been to understand the process by which proteins fold into their characteristic three-dimensional structures. Here, we report the results of atomic-level molecular dynamics simulations, over periods ranging between 100 μs and 1 ms, that reveal a set of common principles underlying the folding of 12 structurally diverse proteins. In simulations conducted with a single physics-based energy function, the proteins, representing all three major structural classes, spontaneously and repeatedly fold to their experimentally determined native structures. Early in the folding process, the protein backbone adopts a nativelike topology while certain secondary structure elements and a small number of nonlocal contacts form. In most cases, folding follows a single dominant route in which elements of the native structure appear in an order highly correlated with their propensity to form in the unfolded state.
                Bookmark

                Author and article information

                Journal
                Wiley Interdisciplinary Reviews: Computational Molecular Science
                WIREs Comput Mol Sci
                Wiley
                17590876
                March 2018
                March 2018
                November 13 2017
                : 8
                : 2
                : e1347
                Affiliations
                [1 ]Department of Physics; Virginia Tech; Blacksburg VA USA
                [2 ]Department of Computer Science; Virginia Tech; Blacksburg VA USA
                [3 ]Center for Soft Matter and Biological Physics; Virginia Tech; Blacksburg VA USA
                [4 ]Early Stage Pharmaceutical Development; Genentech Inc.; South San Francisco, CA USA
                Article
                10.1002/wcms.1347
                10c06a3f-d314-4a56-9300-8c9eface4d8e
                © 2017

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article